Osimertinib in EGFR-Mutated Lung Cancer
- PMID: 33596364
- DOI: 10.1056/NEJMc2033951
Osimertinib in EGFR-Mutated Lung Cancer
Comment in
-
Osimertinib in EGFR-Mutated Lung Cancer. Reply.N Engl J Med. 2021 Feb 18;384(7):675-676. doi: 10.1056/NEJMc2033951. N Engl J Med. 2021. PMID: 33596365 No abstract available.
Comment on
-
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous